Public interest and expectations concerning commercial genotyping and genetic risk assessment

Personalized Medicine

Volumn 6, Issue 3, 2009, Pages 329-341

  Makeeva, Oksana A ^a   Markova, Valentina V ^a   Puzyrev, Valery ^a  

^a RESEARCH INSTITUTE OF MEDICAL GENETICS   (Russian Federation)

Author keywords

Common diseases; Genetic risk assessment; Genetic testing; Genomic medicine; Lifestyle; Predictive diagnostics; Public attitude; Survey

Indexed keywords

ANXIETY; ARTICLE; ATTITUDE TO HEALTH; CLINICAL ASSESSMENT; DECISION MAKING; DISEASE MARKER; EDUCATIONAL STATUS; GENETIC ANALYSIS; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEALTH STATUS; HEALTH SURVEY; HUMAN; LIFESTYLE MODIFICATION; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; SOCIAL STATUS;

EID: 67651171627     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.09.14     Document Type: Article

References (24)

1. Hunter DJ, Khoury MJ, Drazen JM: Letting the genome out of the bottle - will we get our wish? N. Engl. J. Med. 358 (2), 105-107 (2008).
2. Feero WG, Guttmacher AE, Collins FS: The genome gets personal - almost. JAMA 299(11), 1351-1352 (2008).
3. Henneman L, Timmermans DRM, Wal van der G: Public attitudes toward genetic testing: perceived benefits and objections. Genet. Test. 10(2), 139-145 (2006).
4. Sanderson SC, Wardle J, Jarvis MJ, Humphries SE: Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev. Med. 39 (3), 458-464 (2004).
5. Ludman EJ, Curry SJ, Hoffman E, Taplin S: Women's knowledge and attitudes about genetic testing for breast cancer susceptibility. Eff. Clin. Pract. 2(4), 158-162 (1999).
6. Toiviainen H, Jallinoja P, Aro AR, Hemminki E: Medical and lay attitudes towards genetic screening and testing in Finland. Eur. J. Hum. Genet. 11, 565-572 (2003).
7. Calsbeek H, Morten M, Bensing J, Rijken M: Knowledge and attitudes towards genetic testing, a 2 year follow-up study in patients with asthma, diabetes mellitus and cardiovascular disease. J. Genet. Couns. 16(4), 493-504(2007).
8. Lerman C, Shields AE: Genetic testing for cancer susceptibility: the promise and the pitfalls. Nat. Rev. Cancer 4(3), 235-241 (2004).
9. Press NA, Yasui Y, Susan Reynolds S, Durfy SJ, Burke W: Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am. J. Hum. Genet. 99 (2), 99-110 (2001).
10. Shaw JS, Bassi KL: Lay attitudes toward genetic testing susceptibility to inherited diseases. J Health Psychol. 6(4), 405-423 (2001).
11. Singer E, Couper MP, Raghunathan TE, Van Hoewyk J, Antonucci TC: Trends in US attitudes toward genetic testing, 1990-2004. Public Opin. Q. 72(3), 446-458 (2008).
12. Wright AJ, Takeichi C, Whitwell SC, Hankins M, Marteau TM: The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study. Clin. Genet. 73(4), 306-314 (2008).
13. Janssens ACJW, van Duijn CM: Genome-based prediction of common diseases: advances and prospects. Hum. Mol. Genet. 17(R2), R166-R173 (2008).
14. Ginsburg GS: Genomic medicine: 'grand challenges' in the translation of genomics to human health. Eur. J. Hum. Genet. 16, 873-874 (2008).
15. Brand A, Brand H, Schulte in den Bäumen T: The impact of genetics and genomics on public health. Eur. J. Hum. Genet. 16 (1), 5-13 (2008).
16. Humphries SE, Cooper JA, Talmud PJ, Miller GJ: Candidate gene genotypes, along ith conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin. Chem. 53, 8-16 (2007).
17. Feero WG: Genetics of common disease: a primary care priority aligned with a teachable moment? Genet. Med. 10(2), 81-82 (2008).
18. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J: Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a Phase II exploratory trial. J. Health Psychol. 13 (4), 481-494 (2008).
19. Sanderson SC, Wardle J: Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers. Health Educ. Rehav. 32 (5), 640-653 (2005).
20. Wright AJ, Weinman J, Marteau TM: The impact of learning of a genetic predisposition to nicotine dependence: an analogue study. Tob. Control 12 (2), 227-230 (2003).
21. Wright AJ, Takeichi C; Whitwell SC, Hankins M, Marteau TM: The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study. Clin. Genet. 73(4), 306-314 (2008).
22. Sanderson SC, Michie S: Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin. Genet. 71(6), 501-510 (2007).
23. McBride CM, Bepler G, Lipkus IM et al.: Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol. Biomarkers Prev. 11(6), 521-528 (2002).
24. Lerman C, Gold K, Audrain J et al.: Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol. 16(1), 87-99 (1997).